Th1 cytokines synergize to change gene expression and promote corticosteroid insensitivity in pediatric airway smooth muscle

• Published in: Respiratory research Vol. 23; no. 1; p. 126
• Main Authors: Jackson, Devine, Walum, Joshua, Banerjee, Priyanka, Lewis, Brandon W, Prakash, Y S, Sathish, Venkatachalem, Xu, Zhaohui, Britt, Jr, Rodney D
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 16.05.2022; BioMed Central; BMC
• Subjects: Air flow; Airway (Medicine); Airway smooth muscle; Antibiotics; Asthma; Chemokines; Corticoids; Corticosteroids; Cytokines; Demographic aspects; Fluticasone; Gene expression; Gene sequencing; Genes; Genetic aspects; Genetic engineering; Health aspects; IFNγ; Inflammation; Lymphocytes T; Muscle contraction; Muscles; Neonates; Network hubs; Pathogenesis; Patient outcomes; Pediatrics; Physiological aspects; Propionic acid; Quality control; Respiratory tract; Respiratory tract diseases; Ribonucleic acid; RNA; Signal transduction; Signaling; Smooth muscle; Steroids; Synergism; TNFα; Transcription factors; Transplants & implants; Tumor necrosis factor-α; γ-Interferon; United States; IFNγ; TNFα; Corticosteroids; Airway smooth muscle
• ISSN: 1465-993X; 1465-9921; 1465-993X; 1465-9921
• DOI: 10.1186/s12931-022-02046-1

Corticosteroids remain a key therapy for treating children with asthma. Patients with severe asthma are insensitive, resistant, or refractory to corticosteroids and have poorly controlled symptoms that involve airway inflammation, airflow obstruction, and frequent exacerbations. While the pathways that mediate corticosteroid insensitivity in asthma remain poorly defined, recent studies suggest that enhanced Th1 pathways, mediated by TNFα and IFNγ, may play a role. We previously reported that the combined effects of TNFα and IFNγ promote corticosteroid insensitivity in developing human airway smooth muscle (ASM). To further understand the effects of TNFα and IFNγ on corticosteroid sensitivity in the context of neonatal and pediatric asthma, we performed RNA sequencing (RNA-seq) on human pediatric ASM treated with fluticasone propionate (FP), TNFα, and/or IFNγ. We found that TNFα had a greater effect on gene expression (~ 1000 differentially expressed genes) than IFNγ (~ 500 differentially expressed genes). Pathway and transcription factor analyses revealed enrichment of several pro-inflammatory responses and signaling pathways. Interestingly, treatment with TNFα and IFNγ augmented gene expression with more than 4000 differentially expressed genes. Effects of TNFα and IFNγ enhanced several pro-inflammatory genes and pathways related to ASM and its contributions to asthma pathogenesis, which persisted in the presence of corticosteroids. Co-expression analysis revealed several gene networks related to TNFα- and IFNγ-mediated signaling, pro-inflammatory mediator production, and smooth muscle contractility. Many of the co-expression network hubs were associated with genes that are insensitive to corticosteroids. Together, these novel studies show the combined effects of TNFα and IFNγ on pediatric ASM and implicate Th1-associated cytokines in promoting ASM inflammation and hypercontractility in severe asthma.